Skip to main content
Clinical Trials/NCT01142570
NCT01142570UnknownNot Applicable

Effect of Enteral Nutrition Enriched in Protein and Based on Indirect Calorimetry Measurement in Chronically Critically Ill Patients

Rabin Medical Center0 sites60 target enrollmentStarted: September 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
60
Primary Endpoint
Successful weaning from ventilation

Study Overview

Brief Summary

This is a single-center, prospective, randomized, comparative, double-blind controlled clinical study intended to establish 1) the optimal method of determining calorie requirements and 2) the optimal amount of protein supply in chronically ventilated patients.

Detailed Description

The study will be performed in a chronic ventilation department.

Enrolled patients will be randomly allocated to receive calories as dictated by:

The Harriss-Benedict formula (Group 1) or Indirect Calorimetry (Group 2)

After one week of admission to the hospital department and study enrollment we will review the first results of the study.

After seven days of hospitalization and study enrollment patients who have not been weaned from the ventilator, will be divided into three groups.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
65 Years to 90 Years (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Chronically Mechanical Ventilated Patients (more than 21 days of Mechanical Ventilation) by tracheostomy,
  • •Between ages 65-90

Exclusion Criteria

  • •Patient over age 90 and younger the age of 65
  • •PH level less than 7.3 due to metabolic causes.
  • •A patient with blood albumin level less than 2.2 g / dl

Arms & Interventions

Group 1

Active Comparator

Patients will be receive caloric support as dictated by Hariss-Benedict Formula (Group 1)

Intervention: Caloric Support (Group 1) (Other)

Group 2

Active Comparator

Patients will be receive caloric support as dictated by Indirect Calorimetry (Group 2)

Intervention: Caloric Support (Group 2) (Other)

Group 1A

Active Comparator

After seven days of hospitalization and study enrollment patients who have not been weaned from ventilator, will be divided into three groups.

Patients in the first(Group 1A)group will receive caloric support calculated by the HARISS BENEDICT equation and protein dose of 1.1 to 1.5 grams per kilogram weight.

Intervention: Protein dose of 1.1 to 1.5 grams per kilogram weight. (Dietary Supplement)

Group 2A

Active Comparator

After seven days of hospitalization and study enrollment patients who have not been weaned from ventilator, will be divided into three groups.

Patients in the second group(Group 2A) will receive caloric support as measured by indirect calorimetry and will receive protein at 1.1 grams per kilogram weight.

Intervention: Protein at 1.1 grams per kilogram weight. (Dietary Supplement)

Group 3A

Active Comparator

After seven days of hospitalization and study enrollment patients who have not been weaned from ventilator, will be divided into three groups.

Patients in the third group will receive caloric support as measured by indirect calorimetry and will receive protein at a dose of 1.5 grams per kilogram weight.

Intervention: protein at a dose of 1.5 grams per kilogram weight. (Dietary Supplement)

Outcomes

Primary Outcomes

Successful weaning from ventilation

Time Frame: At one, four and eight weeks

Spontaneous breathing

Length of hospital stay

Time Frame: At 8 weeks

Length of hospitalization, in days

Readmission to Intensive Care Unit

Time Frame: At four and eight weeks.

Readmission to Intensive Care Unit Mortality

Time Frame: At eight weeks

Length of mechanical ventilation

Time Frame: At one, four and eight weeks

Length of mechanical ventilation in days/hours

Secondary Outcomes

  • Infectious diseases incidence(At one, four and eight weeks)
  • Development and progression of pressure ulcers(At one, four and eight weeks)
  • Checked daily insulin intake among different groups of patients(After one, four and eight weeks)

Investigators

Sponsor Class
Other

Similar Trials